Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats
暂无分享,去创建一个
[1] Janet B W Williams,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[2] G. Aston-Jones,et al. α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking , 2011, Biological Psychiatry.
[3] TF Newton. A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA , 2011, Clinical pharmacology and therapy.
[4] Udi E. Ghitza,et al. Clonidine blocks stress-induced craving in cocaine users , 2011, Psychopharmacology.
[5] Y. Shaham,et al. Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats , 2011, Psychopharmacology.
[6] B. Everitt,et al. Selective Norepinephrine Reuptake Inhibition by Atomoxetine Prevents Cue-Induced Heroin and Cocaine Seeking , 2011, Biological Psychiatry.
[7] P. Holmes,et al. Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase , 2010, Neuropsychopharmacology.
[8] M. Marinelli,et al. Persistent Increases in Cocaine-Seeking Behavior After Acute Exposure to Cold Swim Stress , 2010, Biological Psychiatry.
[9] S. Erb. Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[10] S. Back,et al. Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats , 2010, Behavioural Brain Research.
[11] R. Sterling,et al. Cocaine withdrawal‐induced anxiety in females: Impact of circulating estrogen and potential use of delta‐opioid receptor agonists for treatment , 2009, Journal of neuroscience research.
[12] D. Buffalari,et al. Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine , 2010, Psychopharmacology.
[13] D. Buffalari,et al. Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse , 2009, Physiology & Behavior.
[14] C. Dackis,et al. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. , 2009, The American journal on addictions.
[15] M. Lapiz-Bluhm,et al. Behavioural Assays to Model Cognitive and Affective Dimensions of Depression and Anxiety in Rats , 2008, Journal of neuroendocrinology.
[16] A. Waters,et al. Disulfiram enhances subjective effects of dextroamphetamine in humans , 2008, Pharmacology Biochemistry and Behavior.
[17] G. Aston-Jones,et al. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence , 2008, Brain Structure and Function.
[18] F. Weiss,et al. Rats with Extended Access to Cocaine Exhibit Increased Stress Reactivity and Sensitivity to the Anxiolytic-Like Effects of the mGluR 2/3 Agonist LY379268 during Abstinence , 2008, Neuropsychopharmacology.
[19] L. Hays,et al. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. , 2008, Drug and alcohol dependence.
[20] D. Baker,et al. Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats , 2007, Psychopharmacology.
[21] R. Spealman,et al. Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys , 2007, Journal of Pharmacology and Experimental Therapeutics.
[22] E. V. Bockstaele,et al. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. , 2007, Progress in neuro-psychopharmacology & biological psychiatry.
[23] A. Preti. REVIEW: New developments in the pharmacotherapy of cocaine abuse , 2007, Addiction biology.
[24] Thomas R Kosten,et al. Treatment Outcome Predictors for Cocaine Dependence , 2007, The American journal of drug and alcohol abuse.
[25] C. Dackis,et al. Outcome predictors in cocaine dependence treatment trials. , 2006, The American journal on addictions.
[26] K. Lynch,et al. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. , 2006, Drug and alcohol dependence.
[27] R. See,et al. Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine , 2006, Behavioural Brain Research.
[28] R. A. Fuchs,et al. Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats , 2006, Psychopharmacology.
[29] T. Kosten,et al. Emerging pharmacological strategies in the fight against cocaine addiction , 2006, Expert opinion on emerging drugs.
[30] M. Filip,et al. Conditioned rewarding stimulus associated with cocaine self-administration reverses the depression of catecholamine brain systems following cocaine withdrawal in rats. , 2005, The international journal of neuropsychopharmacology.
[31] D. Hatsukami,et al. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. , 2005, Addictive behaviors.
[32] X. Zhang,et al. Prazosin, an α-1 Adrenergic Antagonist, Reduces Cocaine-Induced Reinstatement of Drug-Seeking , 2005, Biological Psychiatry.
[33] Michael A. Nader,et al. Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain , 2005, Psychopharmacology.
[34] G. Aston-Jones,et al. β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats , 2005, Psychopharmacology.
[35] X. Zhang,et al. Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. , 2005, Biological psychiatry.
[36] R. Rothman,et al. Evidence for alterations in α2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration , 2004, Neuroscience.
[37] Gary Aston-Jones,et al. Brain substrates for increased drug seeking during protracted withdrawal , 2004, Neuropharmacology.
[38] R. A. Fuchs,et al. Differential Involvement of Orbitofrontal Cortex Subregions in Conditioned Cue-Induced and Cocaine-Primed Reinstatement of Cocaine Seeking in Rats , 2004, The Journal of Neuroscience.
[39] Y. Shaham,et al. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse , 2004, Biological Psychiatry.
[40] B. Rounsaville,et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. , 2004, Archives of general psychiatry.
[41] H. Covington,et al. Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress. , 2003, European journal of pharmacology.
[42] T. Kosten,et al. Prediction of Treatment Outcome by Baseline Urine Cocaine Results and Self‐Reported Cocaine Use for Cocaine and Opioid Dependence , 2003, The American journal of drug and alcohol abuse.
[43] D. Morilak,et al. Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress , 2002, Neuropharmacology.
[44] F. Leri,et al. Blockade of Stress-Induced But Not Cocaine-Induced Reinstatement by Infusion of Noradrenergic Antagonists into the Bed Nucleus of the Stria Terminalis or the Central Nucleus of the Amygdala , 2002, The Journal of Neuroscience.
[45] D. Morilak,et al. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress , 2002, Neuroscience.
[46] R. Sinha. How does stress increase risk of drug abuse and relapse? , 2001, Psychopharmacology.
[47] Y. Shaham,et al. Repeated Lofexidine Treatment Attenuates Stress-Induced, But not Drug Cues-Induced Reinstatement of a Heroin-Cocaine Mixture (Speedball) Seeking in Rats , 2001, Neuropsychopharmacology.
[48] A. Cnaan,et al. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. , 2001, Drug and alcohol dependence.
[49] Rosemarie A. Martin,et al. The Relationship Between Anxiety Levels and Outcome of Cocaine Abuse Treatment , 2000, The American journal of drug and alcohol abuse.
[50] G. Koob,et al. Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats , 1999, Psychopharmacology.
[51] K. Bucholz,et al. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. , 1999, The American journal of psychiatry.
[52] A. Pert,et al. Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor , 1998, Brain Research.
[53] H. Intengan,et al. Alpha-2a/d adrenoceptor subtype stimulation by guanfacine increases osmolar clearance. , 1997, The Journal of pharmacology and experimental therapeutics.
[54] J. Nobrega,et al. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects , 1996, Brain Research.
[55] Z. Sarnyai,et al. Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats , 1995, Brain Research.
[56] C. McDougle,et al. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. , 1994, Archives of general psychiatry.
[57] Y. K. Fung,et al. Behavioural consequences of cocaine withdrawal in rats , 1994, The Journal of pharmacy and pharmacology.
[58] G. Aston-Jones,et al. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. , 1993, Psychopharmacology.
[59] A. Gorman,et al. Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies , 1992, Pharmacology Biochemistry and Behavior.
[60] J. Wikberg,et al. Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound , 1991 .
[61] J. Wikberg,et al. Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. , 1991, European journal of pharmacology.
[62] S. File,et al. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.
[63] D. Treit. Burying as a defensive response in rats , 1978 .